Protective Disk Helps Reduce CRBSI
ETHICON, Inc., a Johnson & Johnson Company, presents BIOPATCH® Protective Disk with CHG (chlorhexidine gluconate) to be applied around catheters to reduce the risk of catheter-related bloodstream infections (CRBSIs). According to the company, the product offers:
- The ability to be placed directly on the skin at the point of catheter insertion and provide 7 days of continuous active antisepsis.
- Design and packaging with easy-to-follow instructions and clearly marked “up” arrows to signify correct application with respect to skin orientation of the product.
- Color-coded elements to instantly identify the size and center-hole diameter of the product.